Medline Inc. has publicly filed a Form S-1 registration statement with the Securities and Exchange Commission (SEC) as it prepares for its initial public offering (IPO) of common stock.
The provider of medical and surgical products and supplies will be listed under the symbol MDLN on the Nasdaq Global Select Market if the offering is completed.
“The number of shares to be offered and the price range and other terms for the offering have not yet been determined,” Medline said in an Oct. 28 press release. The company added that there can be “no assurance as to whether or when the offering may be commenced or completed.”
Goldman Sachs & Co., Morgan Stanley, BofA Securities, and J.P. Morgan are acting as lead bookrunning managers for the proposed offering, Medline said.
The company, founded in 1966 by brothers Jon and Jim Mills, went public in 1972, then became a private company again in 1977. Medline entered the ambulatory surgery centers market in 2008, the physician office market in 2010, and the orthopedic surgery market in 2014.
Blackstone, Carlyle, and Hellman & Friedman, a group of private-equity companies, bought a majority stake in Medline in 2021.
The company’s product offerings include equipment and supplies for the wound care, diagnostics, lab, surgical, pharmacy, textiles, vascular care and therapy and rehabilitation segments of health care. Durable medical equipment lines include bath safety, transfer equipment, walking aids, wheelchairs, beds and support surfaces, incontinence supplies, respiratory therapy, urology supplies and ostomy supplies.
In October 2023, Home Care Delivered (HCD) acquired Medline’s DMEPOS supplier business unit. “With the transition of Medline’s DMEPOS supplier assets to HCD, a company that shares in our commitment to exceptional service and patient care, Medline will continue to focus on its core role as an industry leader in the manufacturing and distribution of quality medical supplies,” said Brad Mariam, currently Medline’s executive vice president of non-acute sales.
